University of Notre Dame

Notre Dame researchers to create material for new antimicrobial mask

2-Jun-2020 2:55 PM EDT, by University of Notre Dame

Newswise — Not long after the coronavirus pandemic began impacting the nation, hospitals and other health services began running into shortages of personal protective equipment such as face masks. Typical masks can help prevent the transmission of disease, but have a one-time use. Researchers at the University of Notre Dame are working to develop a new fabric for antimicrobial masks that could potentially be reusable.

Funded by the National Science Foundation through a Rapid Response Research (RAPID) grant, scientists and engineers are collaborating to translate existing water filtration technology to create a new fabric that will not only capture viruses, like the coronavirus, but also deactivate them.

“Our team previously created a proprietary composite nanofiber material for water filtration that we believed could be fairly easily translated and utilized to filter air. Once the pandemic hit, we began to think more critically about how we could make an air filtration material for face masks that not only meets a critical need for health care professionals, but improves them,” said Nosang Vincent Myung, the Keating Crawford Endowed Professor in Chemical and Biomolecular Engineering at Notre Dame and co-lead on the project.

Through a decade-long collaboration, Myung and David Cwiertny, professor of civil and environmental engineering at the University of Iowa, developed a new material that maximized water filtration performance while minimizing the cost. By using this material’s unique formula, the researchers will aim to mimic the pathogen-capturing process for air filtration as well as include a biocidal or antimicrobial function.

As a part of the team, Patrick O’Shaughnessy, professor of occupational and environmental health at the University of Iowa, will assess the efficiency of the material’s ability for capturing airborne particles. Additionally, Kyle Bibby, associate professor and the Wanzek Collegiate Chair in the Department of Civil and Environmental Engineering and Earth Sciences at Notre Dame, will utilize his expertise to test if it’s effective, and how successful the material is at deactivating airborne viruses.

“The water filter materials Nosang and I developed have always been hybrids — both blocking and reacting with molecules. Now we are looking forward to applying this same concept to a product that could protect people within the health services industry and those that may be exposed to other air-compromised environments,” said Cwiertny, co-lead on the project.

Myung and Bibby are affiliated with Notre Dame’s Advanced Diagnostics and Therapeutics initiative.




Filters close

Showing results

110 of 4578
Newswise: UCLA Researcher’s Team Finds Common Blood Pressure Medications do not Increase COVID-19 Risk
Released: 18-Jan-2021 12:05 PM EST
UCLA Researcher’s Team Finds Common Blood Pressure Medications do not Increase COVID-19 Risk
UCLA Fielding School of Public Health

Dr. Marc Suchard, of the UCLA Fielding School of Public Health, co-led international research team looking at two widely used types of blood pressure drugs.

Newswise: UCLA Fielding School of Public Health Researchers Say Mask Mandates Could add $1 Trillion to the U.S. GDP
Released: 18-Jan-2021 12:05 PM EST
UCLA Fielding School of Public Health Researchers Say Mask Mandates Could add $1 Trillion to the U.S. GDP
UCLA Fielding School of Public Health

The team, including UCLA Fielding School of Public Health professors Anne Rimoin and Christina Ramirez, found that near-universal adoption of nonmedical masks in public, combined with complementary public health measures, could successfully eliminate spread of the infection. and add $1 Trillion to the U.S. GDP.

Released: 18-Jan-2021 10:45 AM EST
Mount Sinai Researchers Build Models Using Machine Learning Technique to Enhance Predictions of COVID-19 Outcomes
Mount Sinai Health System

Mount Sinai researchers have published one of the first studies using federated learning to examine electronic health records to better predict how COVID-19 patients will progress.

Newswise:Video Embedded pregnant-women-should-consider-taking-the-covid-19-vaccine
VIDEO
Released: 18-Jan-2021 7:50 AM EST
Pregnant women should consider taking the COVID-19 vaccine.
University of Washington School of Medicine

f pregnant individuals catch COVID they will generally get sicker than non-pregnant individuals. They also more commonly end up on ECMO [heart-lung support], in the ICU or on ventilators.

Newswise: Have allergies? Worried about COVID-19 vaccine? Don’t be.
Released: 18-Jan-2021 7:40 AM EST
Have allergies? Worried about COVID-19 vaccine? Don’t be.
UW Medicine

Even people who have experienced severe allergic reactions to food, latex, pets, pollen, or bee stings should get the coronavirus vaccine, UW Medicine allergy and infectious disease experts say.

Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.


Showing results

110 of 4578

close
1.21703